Variant report

Variant	nsv1027270
Chromosome Location	chr9:6152434-6328227
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:1325)
CpG islands
(count:244)
Chromatin interactive
region (count:31)
LncRNA
region (count:5)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:1325 , 50 per page) page: 1 2 3 4 5 6 7 ... 27

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr9:6306047-6306247	HepG2	liver:	n/a	n/a
2	ARID3A	chr9:6236398-6236588	HepG2	liver:	n/a	n/a
3	ARID3A	chr9:6272234-6272566	HepG2	liver:	n/a	n/a
4	ARID3A	chr9:6236968-6237134	HepG2	liver:	n/a	n/a
5	ARID3A	chr9:6238753-6239428	HepG2	liver:	n/a	n/a
6	ARID3A	chr9:6197394-6197552	HepG2	liver:	n/a	n/a
7	ATF2	chr9:6184846-6185494	GM12878	blood:	n/a	n/a
8	ATF2	chr9:6184965-6185468	GM12878	blood:	n/a	n/a
9	ATF2	chr9:6197314-6197660	H1-hESC	embryonic stem cell:	n/a	n/a
10	BACH1	chr9:6212812-6213039	K562	blood:	n/a	n/a
11	BATF	chr9:6185007-6185418	GM12878	blood:	n/a	n/a
12	BATF	chr9:6243750-6244097	GM12878	blood:	n/a	chr9:6243981-6243992
13	BATF	chr9:6184773-6185635	GM12878	blood:	n/a	n/a
14	BATF	chr9:6243774-6244147	GM12878	blood:	n/a	chr9:6243981-6243992
15	BATF	chr9:6186725-6187026	GM12878	blood:	n/a	n/a
16	BCL11A	chr9:6185001-6185445	GM12878	blood:	n/a	n/a
17	BCL11A	chr9:6185090-6185360	GM12878	blood:	n/a	n/a
18	BCL11A	chr9:6243799-6244059	GM12878	blood:	n/a	n/a
19	BCLAF1	chr9:6184828-6185523	GM12878	blood:	n/a	n/a
20	BHLHE40	chr9:6306060-6306216	GM12878	blood:	n/a	n/a
21	BHLHE40	chr9:6243865-6244064	GM12878	blood:	n/a	n/a
22	BHLHE40	chr9:6238901-6239586	HepG2	liver:	n/a	n/a
23	BRCA1	chr9:6238263-6238286	Hela-S3	cervix:	n/a	n/a
24	BRCA1	chr9:6215680-6215690	Hela-S3	cervix:	n/a	n/a
25	BRCA1	chr9:6152733-6153851	Hela-S3	cervix:	n/a	n/a
26	BRCA1	chr9:6218063-6218503	Hela-S3	cervix:	n/a	n/a
27	BRCA1	chr9:6305856-6306260	Hela-S3	cervix:	n/a	n/a
28	CBX3	chr9:6173953-6174243	K562	blood:	n/a	n/a
29	CBX3	chr9:6173999-6174182	K562	blood:	n/a	n/a
30	CBX3	chr9:6173885-6174320	HCT-116	colon:	n/a	n/a
31	CEBPB	chr9:6272208-6272574	HepG2	liver:	n/a	chr9:6272425-6272434 chr9:6272425-6272434 chr9:6272425-6272434 chr9:6272423-6272434 chr9:6272424-6272435 chr9:6272425-6272434 chr9:6272423-6272436
32	CEBPB	chr9:6272287-6272514	HepG2	liver:	n/a	chr9:6272425-6272434 chr9:6272425-6272434 chr9:6272425-6272434 chr9:6272423-6272434 chr9:6272424-6272435 chr9:6272425-6272434 chr9:6272423-6272436
33	CEBPB	chr9:6183141-6183440	HepG2	liver:	n/a	n/a
34	CEBPB	chr9:6272244-6272620	A549	lung:	n/a	chr9:6272425-6272434 chr9:6272425-6272434 chr9:6272425-6272434 chr9:6272423-6272434 chr9:6272424-6272435 chr9:6272425-6272434 chr9:6272423-6272436
35	CEBPB	chr9:6277440-6277797	A549	lung:	n/a	chr9:6277616-6277627
36	CEBPB	chr9:6236998-6237031	K562	blood:	n/a	n/a
37	CEBPB	chr9:6277378-6277863	MCF-7	breast:	n/a	chr9:6277616-6277627
38	CEBPB	chr9:6272319-6272559	H1-hESC	embryonic stem cell:	n/a	chr9:6272425-6272434 chr9:6272425-6272434 chr9:6272425-6272434 chr9:6272423-6272434 chr9:6272424-6272435 chr9:6272425-6272434 chr9:6272423-6272436
39	CEBPB	chr9:6236864-6237147	A549	lung:	n/a	chr9:6237021-6237032
40	CEBPB	chr9:6277414-6277814	Hela-S3	cervix:	n/a	chr9:6277616-6277627
41	CEBPB	chr9:6229586-6229823	A549	lung:	n/a	n/a
42	CEBPB	chr9:6304269-6304536	Hela-S3	cervix:	n/a	n/a
43	CEBPB	chr9:6184970-6185710	GM12878	blood:	n/a	n/a
44	CEBPB	chr9:6229679-6229728	HepG2	liver:	n/a	n/a
45	CEBPB	chr9:6277433-6277801	ECC-1	luminal epithelium:	n/a	chr9:6277616-6277627
46	CEBPB	chr9:6183186-6183557	A549	lung:	n/a	n/a
47	CEBPB	chr9:6272207-6272577	MCF-7	breast:	n/a	chr9:6272425-6272434 chr9:6272425-6272434 chr9:6272425-6272434 chr9:6272423-6272434 chr9:6272424-6272435 chr9:6272425-6272434 chr9:6272423-6272436
48	CEBPB	chr9:6188960-6189155	Hela-S3	cervix:	n/a	n/a
49	CEBPB	chr9:6183100-6183422	K562	blood:	n/a	n/a
50	CEBPB	chr9:6183160-6183360	H1-hESC	embryonic stem cell:	n/a	n/a

(count:244 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr9:6241371-6241421	PANC-1	pancreas:	n/a
2	chr9:6252007-6252057	HMEC	breast:	n/a
3	chr9:6252007-6252057	MCF-7	breast:	n/a
4	chr9:6241371-6241421	NHDF-neo	bronchial:	n/a
5	chr9:6326904-6326954	ECC-1	luminal epithelium:	n/a
6	chr9:6252007-6252057	CMK	blood:	n/a
7	chr9:6328010-6328060	NH-A	brain:	n/a
8	chr9:6241371-6241421	IMR90	lung:	fetal
9	chr9:6252007-6252057	HCPEpiC	choroid plexus:	n/a
10	chr9:6241371-6241421	GM06990	blood:	n/a
11	chr9:6241371-6241421	AG10803	skin:	n/a
12	chr9:6241371-6241421	AG04450	lung:	fetal
13	chr9:6326904-6326954	SAEC	small airway:	n/a
14	chr9:6241371-6241421	HCT-116	colon:	n/a
15	chr9:6326904-6326954	NHBE	bronchial:	n/a
16	chr9:6241371-6241421	AG09319	gingival:	n/a
17	chr9:6241371-6241421	SAEC	small airway:	n/a
18	chr9:6252007-6252057	PrEC	prostate:	n/a
19	chr9:6328010-6328060	BJ	skin:	n/a
20	chr9:6241371-6241421	NB4	blood:	n/a
21	chr9:6328010-6328060	ECC-1	luminal epithelium:	n/a
22	chr9:6252007-6252057	MCF10A-Er-Src	breast:	n/a
23	chr9:6326904-6326954	HAEpiC	amniotic membrane:	n/a
24	chr9:6241371-6241421	HMEC	breast:	n/a
25	chr9:6326904-6326954	HL-60	blood:	n/a
26	chr9:6328010-6328060	GM12892	blood:	n/a
27	chr9:6326904-6326954	HPAEpiC	pulmonary alveolar:	n/a
28	chr9:6241371-6241421	LNCaP	prostate:	n/a
29	chr9:6326904-6326954	HUVEC	blood vessel:	n/a
30	chr9:6328010-6328060	A549	lung:	n/a
31	chr9:6326904-6326954	IMR90	lung:	fetal
32	chr9:6241371-6241421	Hepatocyte	liver:	n/a
33	chr9:6328010-6328060	HNPCEpiC	eye:	n/a
34	chr9:6241371-6241421	Caco-2	colon:	n/a
35	chr9:6241371-6241421	U87	brain:	n/a
36	chr9:6328010-6328060	PrEC	prostate:	n/a
37	chr9:6252007-6252057	HL-60	blood:	n/a
38	chr9:6241371-6241421	NH-A	brain:	n/a
39	chr9:6326904-6326954	NH-A	brain:	n/a
40	chr9:6328010-6328060	HUVEC	blood vessel:	n/a
41	chr9:6328010-6328060	NHDF-neo	bronchial:	n/a
42	chr9:6252007-6252057	HNPCEpiC	eye:	n/a
43	chr9:6326904-6326954	SK-N-SH	brain:	n/a
44	chr9:6328010-6328060	AG04449	skin:	fetal
45	chr9:6328010-6328060	Caco-2	colon:	n/a
46	chr9:6326904-6326954	Jurkat	blood:	n/a
47	chr9:6252007-6252057	AG10803	skin:	n/a
48	chr9:6326904-6326954	T-47D	breast:	n/a
49	chr9:6241371-6241421	HAEpiC	amniotic membrane:	n/a
50	chr9:6252007-6252057	GM12891	blood:	n/a

(count:31 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr9:6307810..6309784-chr9:6311496..6314006,2	K562	blood:
2	chr9:6163094..6165877-chr9:6167250..6170974,4	K562	blood:
3	chr9:6266181..6268457-chr9:6269163..6272196,3	K562	blood:
4	chr9:6266181..6268457-chr9:6269163..6272196,3	K562	blood:
5	chr9:6194592..6195131-chr9:6305762..6306590,2	MCF-7	breast:
6	chr9:6196840..6197620-chr9:6306018..6306519,2	MCF-7	breast:
7	chr9:6163094..6165877-chr9:6167250..6170974,4	K562	blood:
8	chr9:6195102..6195794-chr9:6568308..6568912,2	K562	blood:
9	chr9:6054654..6056123-chr9:6305613..6307254,7	MCF-7	breast:
10	chr9:6234179..6236096-chr9:6238826..6241061,2	K562	blood:
11	chr9:6194592..6195131-chr9:6305762..6306590,2	MCF-7	breast:
12	chr9:6149075..6150608-chr9:6166608..6168151,2	MCF-7	breast:
13	chr9:6055397..6056252-chr9:6305741..6306569,2	K562	blood:
14	chr9:6182316..6185009-chr9:6186082..6187902,2	K562	blood:
15	chr9:6174199..6177048-chr9:6181572..6183383,2	MCF-7	breast:
16	chr9:6163920..6166108-chr9:6170937..6173147,2	MCF-7	breast:
17	chr9:6244528..6246233-chr9:6251156..6253683,2	MCF-7	breast:
18	chr9:6244528..6246233-chr9:6251156..6253683,2	MCF-7	breast:
19	chr9:6241308..6243910-chr9:6245192..6247268,2	MCF-7	breast:
20	chr9:6163367..6165821-chr9:6169712..6171511,2	K562	blood:
21	chr9:6201029..6203540-chr9:6215680..6218483,2	K562	blood:
22	chr9:6174199..6177048-chr9:6181572..6183383,2	MCF-7	breast:
23	chr9:6163367..6165821-chr9:6169712..6171511,2	K562	blood:
24	chr9:6163920..6166108-chr9:6170937..6173147,2	MCF-7	breast:
25	chr13:43706108..43706705-chr9:6170816..6171542,2	MCF-7	breast:
26	chr9:6182316..6185009-chr9:6186082..6187902,2	K562	blood:
27	chr9:6305170..6307719-chr9:6307772..6310215,2	K562	blood:
28	chr9:6234179..6236096-chr9:6238826..6241061,2	K562	blood:
29	chr9:6307810..6309784-chr9:6311496..6314006,2	K562	blood:
30	chr9:6305170..6307719-chr9:6307772..6310215,2	K562	blood:
31	chr9:6196840..6197620-chr9:6306018..6306519,2	MCF-7	breast:

(count:5 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-TPD52L3-1	chr9:6241693-6241785	NONHSAT130126
2	lnc-IL33-2	chr9:6197158-6197248	NONHSAT130125
3	lnc-IL33-1	chr9:6276640-6276974	NONHSAT130127
4	lnc-IL33-2	chr9:6195934-6196846	NONHSAT130125
5	lnc-TPD52L3-1	chr9:6242192-6242734	NONHSAT130126

No data

Variant related genes	Relation type
TPD52L3	TF binding region
ENSG00000233846	TF binding region
ENSG00000237274	TF binding region
ENSG00000228132	TF binding region
IL33	TF binding region
TPD52L3	CpG island
ENSG00000233846	CpG island
ENSG00000237274	CpG island
ENSG00000228132	CpG island
IL33	CpG island
ENSG00000237158	chromatin interactions
ENSG00000137033	chromatin interactions

Extended variants
information (count: 5669 )
Associated
traits (count: 107 )

Variant overlapped rSNPs/rCNVs (count:5669 , 50 per page) page: 1 2 3 4 5 6 7 ... 114

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs546191553	chr9:6152455-6152456	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
2	rs186353086	chr9:6152515-6152516	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
3	rs191258033	chr9:6152524-6152525	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
4	rs554543678	chr9:6152540-6152541	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
5	rs566866696	chr9:6152583-6152584	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs568865226	chr9:6152663-6152664	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs182711260	chr9:6152744-6152745	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs558795182	chr9:6152751-6152752	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
9	rs185002812	chr9:6152780-6152781	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs536539151	chr9:6152863-6152864	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs199794161	chr9:6152891-6152892	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs79549791	chr9:6152892-6152893	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs575292649	chr9:6152896-6152897	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs112135195	chr9:6152903-6152904	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs540386174	chr9:6152913-6152914	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs147838036	chr9:6152916-6152917	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs568672749	chr9:6152953-6152954	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs534243029	chr9:6152969-6152970	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs148906214	chr9:6152990-6152991	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs368424727	chr9:6153016-6153017	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs77546487	chr9:6153038-6153039	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs189865888	chr9:6153039-6153040	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs183218760	chr9:6153048-6153049	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs142256332	chr9:6153050-6153051	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs554322166	chr9:6153053-6153054	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs530127247	chr9:6153135-6153136	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs548227541	chr9:6153145-6153146	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs577281701	chr9:6153165-6153166	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs187758797	chr9:6153182-6153183	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs533896060	chr9:6153184-6153185	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs558553814	chr9:6153199-6153200	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs552484748	chr9:6153215-6153216	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs571102457	chr9:6153316-6153317	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs73396522	chr9:6153351-6153352	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
35	rs575534011	chr9:6153392-6153393	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs193025140	chr9:6153399-6153400	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs556707548	chr9:6153449-6153450	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs574894421	chr9:6153455-6153456	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs73396524	chr9:6153463-6153464	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
40	rs79411458	chr9:6153469-6153470	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs450108	chr9:6153485-6153486	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
42	rs540219742	chr9:6153490-6153491	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs565063594	chr9:6153493-6153494	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs544071508	chr9:6153530-6153531	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs375932036	chr9:6153547-6153548	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs73396526	chr9:6153580-6153581	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
47	rs116718398	chr9:6153634-6153635	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs559965379	chr9:6153635-6153636	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs562714792	chr9:6153665-6153666	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs529808447	chr9:6153706-6153707	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:107)

Disease	PMID	Source
Chronic lymphocytic leukemia	21546498	CNVD
Intracranial aneurysm	16715129	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Disorders of sex development	22290220	CNVD
Glioblastoma multiforme	21080181	CNVD
Sudden cardiac death	19188705	CNVD
Non-small cell lung cancer	21829676	CNVD
Acute myeloid leukemia	16864856	CNVD
Cancer	21183584	CNVD
Non-small cell lung cancer	21952639	CNVD
Disorders of sex development	21048976	CNVD
Neuroblastoma	18923191	CNVD
Intellectual disability	22102821	CNVD
abnormal development	18461090	CNVD
Honadal dysgenesis	21048976	CNVD
Medulloblastoma	21979893	CNVD
Lung cancer	16740712	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Breast cancer	16608533	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Breast cancer	16272173	CNVD
Hepatocellular carcinoma	16750200	CNVD
Breast cancer	17133270	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Cervical cancer	21063398	CNVD
Retinoblastoma	22278416	CNVD
Splenic marginal zone lymphoma	18492102	CNVD
Melanoma	18172304	CNVD
Biliary cancer	19435499	CNVD
Gastric cancer	21586687	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Myopathy	18421352	CNVD
Neuroblastoma	18664255	CNVD
Acute lymphoblastic leukemia	18957548	CNVD
Myeloproliferative neoplasm	17564968	CNVD
Malignant meningioma	17937814	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	17603634	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Oligodendroglial tumors	17285580	CNVD
Cutaneous squamous cell carcinomas	19131950	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Chordoma	18071362	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Renal cell carcinoma	18592004	CNVD
Developmental delay	19490664	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
microdeletion syndrome	16199537	CNVD
Non-syndromic sensorineural hearing loss	21987784	CNVD
Cancer	20164919	CNVD
Chronic myeloid leukemia	21384125	CNVD
Ovarian cancer	21720365	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
small cell lung cancer	20016488	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Developmental delay	21147756	CNVD
Lung cancer	18438408	CNVD
XY gonadal dysgenesis	20685758	CNVD
Urothelial carcinoma	21177765	CNVD
Oral cancer	21386901	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Myelodysplastic syndrome	21251322	CNVD
Breast cancer	21785460	CNVD
Prostate cancer	18632612	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21364760	CNVD
Breast cancer	21858162	CNVD
Renal cell carcinoma	21668985	CNVD
Autism	22495311	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Myelofibrosis	22110671	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Hepatocellular carcinoma	18803288	CNVD
Metastatic melanoma	18483359	CNVD
Glioblastoma	19074898	CNVD
Malignant melanoma	19074898	CNVD
Prostate cancer	16573809	CNVD
Metanephric adenoma	20802469	CNVD
Medulloblastoma	16783165	CNVD
Breast cancer	22522925	CNVD
Autism	20858261	CNVD
Epilepsy	20858261	CNVD
Mental retardation	20858261	CNVD
Schizophrenia	23813976	CNVD
Melanoma	20877625	CNVD
T-cell lymphomas	22341440	CNVD
Renal cell carcinoma	21215367	CNVD
Cancer	21215367	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:859 , 50 per page) page: 1 2 3 4 5 6 7 ... 18

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr9:6135600-6152800	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
2	chr9:6147800-6153800	Weak transcription	Fetal Adrenal Gland	Adrenal Gland
3	chr9:6149800-6153800	Weak transcription	Gastric	stomach
4	chr9:6151600-6152600	Weak transcription	Stomach Mucosa	stomach
5	chr9:6152400-6153200	Enhancers	HUES48 Cell Line	embryonic stem cell
6	chr9:6152400-6153600	Flanking Active TSS	Hela-S3	cervix
7	chr9:6152400-6154400	Enhancers	HUVEC	blood vessel
8	chr9:6152600-6153400	Enhancers	iPS-18 Cell Line	embryonic stem cell
9	chr9:6152600-6154200	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
10	chr9:6152600-6154200	Enhancers	Stomach Mucosa	stomach
11	chr9:6152600-6154200	Enhancers	NHEK	skin
12	chr9:6152800-6153200	Enhancers	HUES64 Cell Line	embryonic stem cell
13	chr9:6152800-6153200	Enhancers	iPS-20b Cell Line	embryonic stem cell
14	chr9:6152800-6153200	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
15	chr9:6152800-6153200	Enhancers	A549	lung
16	chr9:6153000-6153600	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
17	chr9:6153000-6154200	Enhancers	HMEC	breast
18	chr9:6153200-6153600	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
19	chr9:6153200-6153600	Flanking Active TSS	A549	lung
20	chr9:6153200-6159400	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
21	chr9:6153600-6155400	Enhancers	Hela-S3	cervix
22	chr9:6153800-6154000	Enhancers	Gastric	stomach
23	chr9:6153800-6154200	Enhancers	Fetal Adrenal Gland	Adrenal Gland
24	chr9:6159400-6159800	Strong transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
25	chr9:6159800-6160200	ZNF genes & repeats	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
26	chr9:6160200-6173600	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
27	chr9:6165600-6165800	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
28	chr9:6165600-6166200	Enhancers	HUES48 Cell Line	embryonic stem cell
29	chr9:6166200-6166400	Weak transcription	HUES48 Cell Line	embryonic stem cell
30	chr9:6166400-6166800	Enhancers	HUES48 Cell Line	embryonic stem cell
31	chr9:6166600-6167000	Enhancers	HUES64 Cell Line	embryonic stem cell
32	chr9:6166800-6167000	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
33	chr9:6166800-6171000	Weak transcription	HUES48 Cell Line	embryonic stem cell
34	chr9:6168600-6168800	Bivalent Enhancer	iPS DF 6.9 Cell Line	embryonic stem cell
35	chr9:6170600-6172000	Enhancers	Fetal Kidney	kidney
36	chr9:6170800-6172800	Enhancers	HUES64 Cell Line	embryonic stem cell
37	chr9:6170800-6172800	Enhancers	iPS-18 Cell Line	embryonic stem cell
38	chr9:6171000-6171600	Enhancers	iPS-20b Cell Line	embryonic stem cell
39	chr9:6171000-6172600	Enhancers	HUES48 Cell Line	embryonic stem cell
40	chr9:6171000-6172800	Enhancers	HUES6 Cell Line	embryonic stem cell
41	chr9:6171000-6172800	Enhancers	iPS-15b Cell Line	embryonic stem cell
42	chr9:6171000-6172800	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
43	chr9:6171000-6172800	Enhancers	NHDF-Ad	bronchial
44	chr9:6171400-6172800	Enhancers	ES-I3 Cell Line	embryonic stem cell
45	chr9:6171600-6172000	Active TSS	ES-WA7 Cell Line	embryonic stem cell
46	chr9:6171600-6172000	Flanking Active TSS	iPS-20b Cell Line	embryonic stem cell
47	chr9:6172000-6172800	Enhancers	ES-WA7 Cell Line	embryonic stem cell
48	chr9:6172000-6173000	Enhancers	iPS-20b Cell Line	embryonic stem cell
49	chr9:6172400-6172800	Enhancers	H9 Cell Line	embryonic stem cell
50	chr9:6172400-6172800	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links